“Rebuilding Patient Nutrition Across the Care Continuum”
NutriGraft AG is a Basel-based medical nutrition company developing personalized, disease-specific nutrition solutions for GI care. Our clinically grounded platform supports patients across pancreatic disorders, short bowel syndrome, and colorectal cancer, with formulations tailored to key clinical endpoints such as absorption, adaptation, and recovery.
We are creating a more accessible patient experience through a simple, consumer-friendly candy format, while building a phased market strategy from Nutraceuticals to FSMP (Food for Special Medicinal Purpose). NutriGraft’s mission is to bring practical, evidence-based nutrition innovation closer to patients, clinicians, and recovery pathways that need it most.

NutriGraft AG is to be incorporated soon and is currently operated under the leadership of Inferre Consulting GmbH
FOUNDERS

Dr. Yury Makhankov
MD, Ph.D, Medical Affair
LinkedIn
Yury, Co-Founder of NutriGraft, drives clinical and medical strategy to accelerate access, strengthen evidence, and improve patient outcomes globally.

Santoro Di Franco
Professional MSc in Foreign Trade, BA in International Freight Forwarding & Logistics
LinkedIn
Santoro, Co-Founder of NutriGraft, specializes in building and scaling strategic partnerships in health innovation, connecting stakeholders to drive execution-focused, impactful collaborations.

Dr. Avisek Ghose
Ph.D Biophysics
LinkedIn
Avisek, Co-Founder of NutriGraft, drives market access and commercialization strategies to help innovative healthcare solutions reach patients faster and scale sustainably.